U.S. Healthcare Services Stock News

NYSE:HTH
NYSE:HTHBanks

A Look At Hilltop Holdings (HTH) Valuation After Mixed Recent Share Price Performance

Hilltop Holdings: Recent Performance Snapshot Hilltop Holdings (HTH) has been trading around its recent close of US$36.29, with the stock down about 2% over the past month and roughly 8% over the past 3 months. Despite this pullback, the stock shows a total return of about 20% over the past year and around 25% over the past 3 years, with year-to-date performance near 7%. See our latest analysis for Hilltop Holdings. Recent share price weakness, with the 90 day share price return down 7.6%,...
NYSE:SWK
NYSE:SWKMachinery

Is Stanley Black & Decker (SWK) Offering Value After Its Recent 11.8% Share Price Move

Wondering whether Stanley Black & Decker stock at around US$75 is giving you value or asking too much? Price is only half the story; the real question is what you are getting for it. Over the last month the share price has risen 11.8%, yet it is still down 1.7% year to date and up 10.2% over the past year, which can leave the stock looking very different depending on your time frame. Recent coverage has focused on how the stock's multi year performance, including a 3 year return of 3.8% and...
NasdaqGS:HSIC
NasdaqGS:HSICHealthcare

A Look At Henry Schein (HSIC) Valuation After Solid Q1 Update And Reaffirmed Guidance

Henry Schein (HSIC) stock is in focus after first quarter results highlighted steady U.S. dental and technology performance, reaffirmed full year guidance, and an industry report that places clinical execution, not scale, at the center of practice growth. See our latest analysis for Henry Schein. Henry Schein’s recent Q1 update, reaffirmed 2026 outlook and ongoing buybacks have supported sentiment. However, the stock’s 30 day share price return is down 6.07% and its 1 year total shareholder...
NasdaqGM:GUTS
NasdaqGM:GUTSMedical Equipment

Fractyl Health (GUTS) Is Up 14.0% After RJVA-001 Human Trial Nod And Q1 Profitability Shift – Has The Bull Case Changed?

In May 2026, Fractyl Health reported first-quarter 2026 net income of US$9.22 million, reversing a prior-year loss, and secured authorization in the Netherlands to begin a Phase 1/2 first-in-human trial of RJVA-001, its Smart GLP-1 gene therapy candidate for type 2 diabetes. An important detail for investors is that this regulatory clearance makes Fractyl a dual clinical-stage company, advancing both its Revita procedure for post‑GLP‑1 weight maintenance and its Rejuva gene therapy platform...
NasdaqGS:PRGS
NasdaqGS:PRGSSoftware

Progress Software Award Spotlights Agentic RAG And Undervalued AI Potential

Progress Software (NasdaqGS:PRGS) has received a 2026 Artificial Intelligence Excellence Award for its Agentic RAG platform. The award recognizes the platform in the Retrieval Augmented Generation (RAG) category for its role in AI driven data solutions. Agentic RAG focuses on converting unstructured data into governed intelligence for enterprise use. For you as an investor, this award draws attention to how Progress Software is positioning itself around operational AI rather than only...
NYSE:ARDT
NYSE:ARDTHealthcare

How Investors Are Reacting To Ardent Health (ARDT) Fujifilm Synapse Imaging Integration Across Hospitals

In early May 2026, FUJIFILM Healthcare Americas announced a partnership to deploy its Synapse enterprise imaging platform across Ardent Health’s acute care hospitals in six states, integrating radiology and cardiology images within Epic’s electronic health record system. This rollout could materially streamline clinician workflows and enhance diagnostic decision-making, potentially reinforcing Ardent Health’s focus on technology-enabled efficiency across its hospital network. We’ll now...
NYSE:AMN
NYSE:AMNHealthcare

Is It Time To Reassess AMN Healthcare Services (AMN) After Its Recent Share Price Surge?

If you are wondering whether AMN Healthcare Services at around US$28.61 still offers value, the key question is how its current price compares with what the business may be worth. The stock has been volatile recently, with a slight decline of 1.2% over the past week, a strong 47.7% gain over the past month, 89.2% year to date, yet still down 70.3% over three years and 68.0% over five years. This mix of results can change how investors think about both upside and risk. Recent attention on AMN...
NasdaqGS:MGEE
NasdaqGS:MGEEElectric Utilities

Stronger Q1 Results and Follow-On Offerings Could Be A Game Changer For MGE Energy (MGEE)

In early May 2026, MGE Energy, Inc. reported higher first-quarter revenue of US$242.7 million and net income of US$48.48 million, then completed a US$250.00 million follow-on common stock offering of 3,300,331 shares at US$75.75 each with a US$2.8406 discount per share and filed an additional US$175.00 million follow-on offering. This combination of stronger quarterly earnings and sizable equity capital raises highlights management’s focus on funding future needs through the equity market...
NYSE:ARE
NYSE:AREHealth Care REITs

What Alexandria Real Estate Equities (ARE)'s Mixed Q1 Beat Amid Sector Headwinds Means For Shareholders

Alexandria Real Estate Equities recently reported first-quarter 2026 results with earnings above analyst expectations but revenue below forecasts, while shareholders re-elected eight directors and approved executive pay and auditors at the May 13 annual meeting. Broker downgrades citing slower sector recovery, property oversupply, and regulatory uncertainties highlight how life science real estate headwinds are complicating Alexandria’s operating backdrop. We’ll now explore how this earnings...